Trial Profile
A phase II trial evaluating irinotecan with 5-fluorouracil plus leucovorin [folinic acid] in patients with relapsed/refractory upper gastrointestinal tumours.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 22 Sep 2012
Price :
$35
*
At a glance
- Drugs Fluorouracil (Primary) ; Folinic acid (Primary) ; Irinotecan (Primary)
- Indications Gastric cancer; Pancreatic cancer
- Focus Therapeutic Use
- 12 Jan 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 08 Nov 2005 New trial record.